did the fda ban compounded semaglutide Warns on Certain Forms of Weight Loss Wednesday: Low-cost weight

For many patients, that simplicity supports consistency

Since NAD+ synthesis depends on adequate dietary niacin (vitamin B3) and tryptophan, overall nutritional status is relevant in this context

Semaglutide only targets one pathway (GLP-1), while retatrutide goes a step further by also acting on GIP and glucagon receptors

26 May 2026 | Tuesday | News In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs

If you do this in an unsupervised manner outside of the clinical trial, for example, people dont really eat better

Both peptides appear to require indefinite use for sustained weight maintenance, similar to how blood pressure medications require ongoing use to maintain effect